Company Profiles

driven by the PitchBook Platform

BliNK Therapeutics

Description

Developer of novel platform to generate therapeutic and diagnostic monoclonal antibodies towards clinically relevant targets. The company has developed a technology which provides a new way to activate the immune system's B cells to produce antibodies in response to a specific antigen.

2011

Founded

PRIVATE

Status

1-10

Employees

Accelerator/Inc

Latest Deal Type

$2.54M

Total Amount Raised

3

Investors

Description

Developer of novel platform to generate therapeutic and diagnostic monoclonal antibodies towards clinically relevant targets. The company has developed a technology which provides a new way to activate the immune system's B cells to produce antibodies in response to a specific antigen.

Website:

www.blinktherapeutics.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Primary Office

London England
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore BliNK Therapeutics's full profile, request a free trial.

    BliNK Therapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    BliNK Therapeutics Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    BliNK Therapeutics Investors (3)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Cancer Research TechnologyVenture CapitalMinority000 0000000 0000
    Kurma PartnersVenture CapitalMinority000 0000000 0000
    Stevenage Bioscience CatalystAccelerator/Incubator000 0000000 0000
    Cancer Research Technology Venture Capital
    Kurma Partners Venture Capital
    Stevenage Bioscience Catalyst Accelerator/Incubator

    BliNK Therapeutics Board Members (2)

    NameRepresentingRoleSinceContact
    Info
    Irina Staatz-GranzerSelfChairman000 0000
    Nicola Beltraminelli Ph.DSelfBoard Member000 0000
    Irina Staatz-Granzer Chairman Self
    Nicola Beltraminelli Ph.D Board Member Self
    Request full access to PitchBook